Table 2 Summary of clinical pathologic status of non triple-negative cases (non-TNBC)
From: Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women
Characteristic | Â | No. of patients (%) | Â |
|---|---|---|---|
ER/PR+, HER2+ (N = 111) | ER/PR+, HER2- (N =106) | ER/PR-, HER2+ (N =81) | |
AGE AT DIAGNOSIS (y) | |||
  ≤ 40 | 21 (18.9%) | 17 (16.0%) | 11 (13.6%) |
  41 ≤ y ≤ 49 | 42 (37.8%) | 45 (42.5%) | 26 (32.1%) |
  50 ≤ y ≤ 65 | 37 (33.3%) | 33 (31.1%) | 37 (45.7%) |
  > 65 | 11 (9.9%) | 11 (10.4%) | 7 (8.6%) |
HISTOLOGY | |||
  DCIS | 14 (12.6%) | 13 (12.3%) | 8 (9.9%) |
  IDC | 89 (80.2%) | 74 (69.8%) | 69 (85.2%) |
  Others | 8 (7.2%) | 19 (17.9%) | 4 (4.9%) |
GRADE | |||
  1 (well differentiated) | 2 (1.8%) | 4 (3.8%) | 1 (1.2%) |
  2 (moderately differentiated) | 50 (45.0%) | 48 (45.3%) | 12 (14.8%) |
  3 (poorly differentiated) | 52 (46.8%) | 35 (33.0%) | 64 (79.0%) |
  Not determined | 7 (6.3%) | 19 (17.9%) | 4 (4.9%) |
TUMOR SIZE (cm) | |||
  ≤ 2 | 46 (41.4%) | 44 (41.5%) | 19 (23.5%) |
  2 < cm ≤ 5 | 32 (28.8%) | 27 (25.5%) | 40 (49.4%) |
  > 5 | 7 (6.3%) | 2 (1.9%) | 6 (7.4%) |
  Not determined | 26 (23.4%) | 33 (31.1%) | 16 (19.8%) |
LYMPH NODE INFILTRATION | |||
  Positive | 34 (30.6%) | 24 (22.6%) | 33 (40.7%) |
  Negative | 75 (67.6%) | 74 (69.8%) | 45 (55.6%) |
  Not determined | 2 (1.8%) | 8 (7.5%) | 3 (3.7%) |
p53 STATUS | |||
  Positive | 10 (9.0%) | 7 (6.6%) | 28 (34.6%) |
  Negative | 101 (91.0%) | 97 (91.5%) | 53 (65.4%) |
  Not determined |  0 (0.0%) | 2 (1.9%) | 0 (0.0%) |